Papillary Thyroid Ca stained with Anti-Cyclin D1
Cyclin D1 (synonymes: PRAD1, parathyroid adenomatosis 1, CCND1) is a 295 amino acid protein, 36 kDa, which belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclin D1 forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. The protein has been shown to interact with tumour suppressor protein Rb and its expression is regulated positively by Rb. The expression is cell cycle dependant, maximal in G1 and minimal in S phase. Localization is mainly nuclear. In normal tissues, Cyclin D1 expression is restricted to the proliferative zone of epithelial tissues, endothelium and some fibroblasts. There is no expression in lymphoid tissue. Mutations with amplification of the cyclin D1 gene, with overexpression of the protein, which alters cell cycle progression, are observed frequently in a variety of tumours and may contribute to tumourigenesis. In diagnostic pathology, immunohistochemical detection of Cyclin D1 is used mainly for the diagnosis of mantle cell lymphoma. While other methods of cyclin D1 detection are being explored, immunohistochemistry is still widely used and anti-cyclin D1 antibodies remain an essential component in a small B-cell lymphoproliferative disorder panel. Cyclin D1 is also known as U21B31, PRAD1, BCL1, B-Cell Lymphoma 1 Protein, G1/S-Specific Cyclin-D1, B-Cell CLL/Lymphoma 1, BCL-1 Oncogene, PRAD1 Oncogene, Cyclin D1 (PRAD1: Parathyroid Adenomatosis 1), Parathyroid Adenomatosis 1, G1/S-Specific Cyclin D1, BCL-1, CCND1, BCL1, D11S287E
Cyclin D1 (synonymes: PRAD1, parathyroid adenomatosis 1, CCND1) is a 295 amino acid protein, 36 kDa, which belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclin D1 forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. The protein has been shown to interact with tumour suppressor protein Rb and its expression is regulated positively by Rb. The expression is cell cycle dependant, maximal in G1 and minimal in S phase. Localization is mainly nuclear. In normal tissues, Cyclin D1 expression is restricted to the proliferative zone of epithelial tissues, endothelium and some fibroblasts. There is no expression in lymphoid tissue. Mutations with amplification of the cyclin D1 gene, with overexpression of the protein, which alters cell cycle progression, are observed frequently in a variety of tumours and may contribute to tumourigenesis. In diagnostic pathology, immunohistochemical detection of Cyclin D1 is used mainly for the diagnosis of mantle cell lymphoma. While other methods of cyclin D1 detection are being explored, immunohistochemistry is still widely used and anti-cyclin D1 antibodies remain an essential component in a small B-cell lymphoproliferative disorder panel. Cyclin D1 is also known as U21B31, PRAD1, BCL1, B-Cell Lymphoma 1 Protein, G1/S-Specific Cyclin-D1, B-Cell CLL/Lymphoma 1, BCL-1 Oncogene, PRAD1 Oncogene, Cyclin D1 (PRAD1: Parathyroid Adenomatosis 1), Parathyroid Adenomatosis 1, G1/S-Specific Cyclin D1, BCL-1, CCND1, BCL1, D11S287E
